Published 2020-12-01
Keywords
- malaria,
- pregnancy,
- HIV,
- vaccines,
- prevention
How to Cite
1.
Samak AC. Malaria in Pregnancy: an overview. McGill J Med [Internet]. 2020 Dec. 1 [cited 2025 Oct. 7];8(1). Available from: https://mjm.mcgill.ca/article/view/509

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Abstract
N/A
Downloads
Download data is not yet available.
References
- National Center for Infectious Diseases, Division of Parasitic Diseases. Anopheles Mosquitoes. April 23, 2004.
- http://www.cdc.gov/malaria/biology/mosquito/
- Duffy P, Fried M. Antibodies That Inhibit Plasmodium falciparum Adhesion to Chondroitin Sulfate A Are Associated
- with Increased Birth Weight and the Gestational Age of Newborns. Infec. and Immu. 71(11): 6620-3; 2003
- Shulman CE, Graham WJ, Jilo H, et al. Malaria is an important cause of anaemia in primigravidae: evidence from a district hospital in coastal Kenya. Trans R Soc Trop Med Hyg. 90(5):535-9; 1996
- Steketee RW, Wirima JJ, Hightower AW, et al. The effect of malaria and malaria prevention in pregnancy on offspring
- birthweight, prematurity, and intrauterine growth retardation in rural Malawi. Am J Trop Med Hyg. 55(1 Suppl):33-41; 1996
- Menendez C, Ordi J, Ismail MR, et al. The impact of placental malaria on gestational age and birth weight. J Infect Dis. 181(5):1740-5; 2000.
- Ismail MR, Ordi J, Menendez C, et al. Placental pathology in malaria: an histological, immunohistochemical and quantitative study. Human Pathology 31(1):85-93; 2000
- McGready R, Davison BB, Stepniewska K, et al. The effects of Plasmodium falciparum and P. vivax infections on placental
- histopathology in an area of low malaria transmission. Am J Trop Med Hyg. 70(4):398-407; 2004
- Fried M, Duffy PE. Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science 272(5267):1502-4; 1996
- Beeson JG, Rogerson SJ, Cooke BM, et al.. Adhesion of Plasmodium falciparum-infected erythrocytes to hyaluronic acid
- in placental malaria. Nat Med. 6(1):86-90; 2000
- Fried M, Nosten F, Brockman A, et al. Maternal antibodies block malaria. Nature 395(6705):851-2; 1998
- Duffy PE, Fried M. Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with
- increased birth weight and the gestational age of newborns. Infect Immun. 71(11):6620-3; 2003
- McGregor, I.A. Epidemiology, malaria and pregnancy. Am. J. Trop. Med. Hyg. 33 (4), 517-525; 1984
- Rasheed, F.N., Bulmer, J.N., Dun, D.T.,et al. Suppressed peripheral and placental blood lymphoproliferative responses in
- first pregnancies: relevance to malaria. Am. J. Trop. Med. Hyg. 48(2):154-60; 1993
- Shulman, C. E. , Marshall, T. , Dorman, E. K., et al. Malaria in pregnancy: adverse effects on haemoglobin levels and
- birthweight in primigravidae and multigravidae. Tropical Medicine & International Health 6 (10): 770-778; 2001
- Cot M, Brutus L, Pinell V, et al.. Malaria prevention during pregnancy in unstable transmission areas: the highlands of
- Madagascar. Trop Med Int Health. 7(7):565-72; 2002
- Okoko BJ, Enwere G, Ota MO. The epidemiology and consequences of maternal malaria: a review of immunological
- basis. Acta Trop. 87(2):193-205; 2003
- Newman RD, Hailemariam A, Jimma D, et al. Burden of malaria during pregnancy in areas of stable and unstable
- transmission in Ethiopia during a nonepidemic year. J Infect Dis. 187(11):1765-72; 2003
- Omodeo-Sale F, Motti A, Basilico N, et al. Accelerated senescence of human erythrocytes cultured with Plasmodium
- falciparum. Blood 102(2):705-11; 2003
- Steketee RW, Nahlen BL, Parise ME, et al. The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med
- Hyg. 64(1-2 Suppl):28-35; 2001
- Bouyou-Akotet MK, Ionete-Collard DE, Mabika-Manfoumbi M, et al. Prevalence of Plasmodium falciparum infection in
- pregnant women in Gabon. Malar J. 2(1):18; 2003
- Malhotra M, Sharma JB, Batra S, et al. Maternal and perinatal outcome in varying degrees of anemia. Int J Gynaecol Obstet. 79(2):93-100; 2002
- Vassiliadis, S., D. Tsoukatos, I. Athanassakis. Interferoninduced class II expression at the spongiotrophoblastic zone of the murine placenta is linked to fetal rejection and developmental abnormalities. Acta Physiol Scand. 151(4):485;1994
- Fried M, Muga R, Misore A, et al. Malaria Elicits Type 1 Cytokines in the Human Placenta:IFN-g and TNF-a Associated
- with Pregnancy Outcomes. Jour. of Immunol. 160(5): 2523-30; 1998
- Suguitan AL Jr, Leke RG, Fouda G, et al. Changes in the levels of chemokines and cytokines in the placentas of women with Plasmodium falciparum malaria. J Infect Dis. 188(7):1074-82; 2003
- Abrams ET, Brown H, Chensue SW, et al. Host response to malaria during pregnancy: placental monocyte recruitment is
- associated with elevated beta chemokine expression. J Immunol. 170(5):2759-64; 2003
- Crocker IP, Tanner OM, Myers JE, et al. Syncytiotrophoblast degradation and the pathophysiology of the malaria-infected placenta. Placenta 25(4):273-82; 2004
- Leopardi O, Naughten W, Salvia L, et al. Malaric placentas. A quantitative study and clinico-pathological correlations. Pathol Res Pract. 192(9):892-8; 1996
- LeHesran JY, Cot M, Personne P, et al. Maternal placental infection with Plasmodium falciparum and malaria morbidity
- during the first 2 years of life. Am J Epidemiol 146(10):826-31; 1997
- Luxemburger C, McGready R, Kham A, et al. Effects of malaria during pregnancy on infant mortality in an area of low malaria transmission. Am J Epidemiol. 154(5):459-65; 2001
- Tobian AA, Mehlotra RK, Malhotra I, et al. Frequent umbilical cord-blood and maternal-blood infections with Plasmodium falciparum, P. malariae, and P. ovale in Kenya. J Infect Dis. 182(2):558-63; 2000
- Hewson M, Simmer K, Blackmore T. Congenital malaria in a preterm infant. J Paediatr Child Health. 39(9):713-715; 2003
- Olowu WA, Torimiro SE. Congenital malaria in 8 hours old newborn: case report. Niger J Med. Apr-11(2):81-2; 2002
- Fischer PR. Congenital malaria: an African survey. Clin Pediatr (Phila). 36(7):411-3; 1997
- Stoll BJ. The global impact of neonatal infection. Clin Perinatol 1997;24(1):1-21. In: Duffy P. Maternal immunization and
- malaria in pregnancy. Vaccine. 2003; 21: 3358-3361.
- Okoko BJ, Wesumperuma LH, Ota MO, et al. The influence of placental malaria infection and maternal
- hypergammaglobulinemia on transplacental transfer of antibodies and IgG subclasses in a rural West African
- population. J Infect Dis. 184(5):627-32; 2001
- Okoko BJ, Wesumperuma LH, Hart AC. Materno-foetal transfer of H. influenzae and pneumococcal antibodies is influenced by prematurity and low birth weight: implications for conjugate vaccine trials. Vaccine 20(5-6):647-50; 2001
- Duffy P. Maternal immunization and malaria in pregnancy. Vaccine. 2003; 21(24): 3358-61.
- Ismaili J, van der Sande M, Holland MJ, et al. Plasmodium falciparum infection of the placenta affects newborn immune
- responses. Clin Exp Immunol. 133(3):414-21; 2003
- Steketee RW, Wirima JJ, Bloland PB, et al. Impairment of a pregnant woman's acquired ability to limit Plasmodium
- falciparum by infection with human immunodeficiency virus type-1. Am J Trop Med Hyg 55(1 Suppl):42-9; 1996
- Mount AM, Mwapasa V, Elliott SR, et al. Impairment of humoral immunity to Plasmodium falciparum malaria in
- pregnancy by HIV infection. Lancet 363(9424):1860-7; 2004
- Ayisi JG, Branch OH, Rafi-Janajreh A, et al. Does infection with Human Immunodeficiency Virus affect the antibody responses to Plasmodium falciparum antigenic determinants in asymptomatic pregnant women? J Infect. 46(3):164-72; 2003
- Brahmbhatt H, Kigozi G, Wabwire-Mangen F, et al. The effects of placental malaria on mother-to-child HIV transmission in Rakai, Uganda. AIDS 17(17):2539-41; 2003
- Inion I, Mwanyumba F, Gaillard P, et al. Placental malaria and perinatal transmission of human immunodeficiency virus type 1. J Infect Dis. 188(11):1675-8; 2003
- Sirima SB, Sawadogo R, Moran AC, et al. Failure of a chloroquine chemoprophylaxis program to adequately prevent
- malaria during pregnancy in Koupela District, Burkina Faso. Clin Infect Dis. 36(11):1374-82; 2003
- Strategic framework for malaria control during pregnancy in the WHO African Region. Geneva: World Health Organization; 2002.
- van Eijk AM, Ayisi JG, ter Kuile FO, et al. Effectiveness of intermittent preventive treatment with sulphadoxinepyrimethamine for control of malaria in pregnancy in western Kenya: a hospital-based study. Trop Med Int Health 9(3):351-60; 2004
- Newman RD, Parise ME, Slutsker L, et al. Safety, efficacy and determinants of effectiveness of antimalarial drugs during
- pregnancy: implications for prevention programmes in Plasmodium falciparum-endemic sub-Saharan Africa. Trop Med
- Int Health. 8(6):488-506; 2003
- Stoll BJ. The global impact of neonatal infection. Clin Perinatol. 24(1):1-21; 1997
- Steketee RW, Wirima JJ, Hightower AW, et al. The effect of malaria and malaria prevention in pregnancy on offspring
- birthweight, prematurity, and intrauterine growth retardation in rural Malawi. Am J Trop Med Hyg. 55(1 Suppl):33-41; 1996
- Buffet PA, Gamain B, Scheidig C, et al. Plasmodium falciparum domain mediating adhesion to chondroitin sulfate A: a receptor for human placental infection. Proc Natl Acad Sci USA 96(22):12743-8; 1999
- Bill C-9 House of Commons. Canada.
- Winstanley P, Ward S, Snow R, et al Therapy of falciparum malaria in sub-saharan Africa: from molecule to policy. Clin
- Microbiol Rev. 17(3):612-37; 2004
- Global Access to Treatment: Canada's Bill C-9 and the Compulsory Licensing of Pharmaceuticals for Export to
- Countries in Need. Canadian HIV-AIDS Legal Network. July 2004.